| Literature DB >> 30228856 |
Natasha Frasson Pavin1, Aryele Pinto Izaguirry1, Melina Bucco Soares1, Cristiano Chiapinotto Spiazzi1, Andreas Sebastian Loureiro Mendez2, Fábio Gallas Leivas1, Daniela Dos Santos Brum1, Francielli Weber Santos Cibin1.
Abstract
Tribulus terrestris (TT) has been considered as a potential stimulator of testosterone production, which has been related with steroidal saponins prevailing in this plant. Cyclophosphamide (CP) is the most commonly used anticancer and immunosuppressant drug, which causes several toxic effects, especially on the reproductive system. Patients who need to use CP therapy exhibit reduced fertility or infertility, which impacts both physically and emotionally on the decision to use this drug, especially among young men. We hypothesized that the treatment with TT dry extract would protect the male reproductive system against CP toxicity. Mice received dry extract of TT (11 mg/kg) or vehicle by gavage for 14 days. Saline or CP was injected intraperitoneally at a single dose (100 mg/kg) on the 14th day. Animals were euthanized 24 h after CP administration, and testes and epididymis were removed for biochemical and histopathological analysis and sperm evaluation. The dry extract of TT was evaluated by HPLC analysis and demonstrated the presence of protodioscin (1.48%, w/w). CP exposure increased lipid peroxidation, reactive species, and protein carbonylation and altered antioxidant enzymes (SOD, CAT, GPx, GST, and GR). Moreover, acute exposure to CP caused a reduction on 17 β-HSD activity, which may be related to the reduction in serum testosterone levels, histopathological changes observed in the testes, and the quality of the semen. The present study highlighted the role of TT dry extract to ameliorate the alterations induced by CP administration in mice testes, probably due to the presence of protodioscin.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30228856 PMCID: PMC6136460 DOI: 10.1155/2018/5758191
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1(a) Chromatogram of protodioscin reference standard at 500 μg/mL in 70% hydroethanolic solution. (b) Chromatogram of aqueous extract (infusion) from TT, prepared on concentration of 0.056 g/5 mL. 1—Protodioscin retained at 43.03 and 42.99 minutes for reference standard solution and aqueous extract, respectively; detection at 250 nm.
The effect of CP (100 mg/kg) and dry extract of TT (11 mg/kg) on biochemical assays in testes of mice.
| Control | TT | CP | CP + TT | |
|---|---|---|---|---|
| RS (FU) | 128.20 ± 17.06 | 142.20 ± 16.14# | 165.05 ± 8.92∗ | 141.16 ± 9.04# |
| TBARS (nmol MDA/mg protein) | 90.61 ± 6.62 | 88.32 ± 8.31# | 141.20 ± 9.18 ∗ | 75.69 ± 0.68# |
| Carbonyl (nmol carbonyl/mg protein) | 2.63 ± 0.37 | 2.78 ± 0.37 | 3.26 ± 0.69∗ | 2.96 ± 0.67 |
| SOD (IU) | 52.83 ± 3.52 | 51.86 ± 3.07# | 61.30 ± 4.34∗ | 54.67 ± 3.75# |
| CAT (U Cat/mg protein) | 0.95 ± 0.08 | 1.03 ± 0.074 | 1.12 ± 0.10∗ | 0.86 ± 0.05# |
| GPx (mmol/min/mg protein) | 5.86 ± 0.46 | 5.79 ± 0.20# | 5.13 ± 0.31∗ | 7.03 ± 0.19∗# |
| GR (nmol/min/mg protein) | 25.05 ± 3.92 | 25.96 ± 2.15# | 31.54 ± 2.44∗ | 29.10 ± 2.55 |
| GST (nmol CDNB/mg protein) | 814.80 ± 83.16 | 1137.57 ± 86.70∗# | 1321.62 ± 88.65∗ | 1061.55 ± 115.02∗# |
| GSH (nmol GSH/g tissue) | 269.89 ± 6.22 | 264.88 ± 9.39 | 270.35 ± 6.28 | 272.44 ± 8.29 |
All the values are expressed as mean ± SD. ∗P < 0.05 compared with group control. #P < 0.05 compared with group CP.
Figure 2Effect of CP (100 mg/kg) and the dry extract of TT pretreatment (11 mg/kg) on 17β-HSD activity in testes. All the values are expressed as mean ± SD (n = 6). ∗P < 0.01, compared to the control group.
Figure 3Effect of CP (100 mg/kg) and the dry extract of TT pretreatment (11 mg/kg) on serum testosterone (T) concentrations. All the values are expressed as mean ± SD (n = 6). ∗P < 0.01, compared with the control group.
The effect of CP (100 mg/kg) and dry extract of TT (11 mg/kg) on epididymal sperm characteristics.
| Control | TT | CP | CP + TT | |
|---|---|---|---|---|
| VCL ( | 81.70 ± 10.31 | 93.70 ± 17.77 | 60.92 ± 6.55∗ | 88.57 ± 3.52 |
| Motility (%) | 34.57 ± 6.42 | 43.40 ± 10.37 | 20.37 ± 5.35∗ | 53.23 ± 5.85∗# |
| Vigor (1–5) | 4.25 ± 0.50 | 4.25 ± 0.50 | 3.25 ± 0.50∗ | 4.0 ± 0.01 |
| Integrity (%) | 36.83 ± 8.03 | 36.75 ± 10.25 | 20.83 ± 6.60∗ | 36.16 ± 5.96 |
All the values are expressed as mean ± SD. ∗P < 0.05 compared with group control. #P < 0.05 compared with group CP.
Figure 4Photomicrograph of seminiferous tubules from mice in the control group. (a) Normal testicular architecture (100x). (b) Note the normal spermatogenic epithelium composed by different spermatogenic cells (arrow) and Leydig cells (L) (400x). HE staining.
Figure 5Photomicrograph of seminiferous tubules from mice treated with CP. (a)–(b) Disorganized seminiferous tubules (100–200x). (c) Note the congestion of the blood vessels (▲) (200x) and (d) exfoliated germ cells (∗) (400x). HE staining.
Figure 6Correlation of hormone dehydroepiandrosterone sulphate (DHEA-S) with the levels of testosterone.